Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations
NCT03145324 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 166
Last updated 2021-10-05
Summary
To collect the immunisation history of participants enrolled in a previous vaccine study (REC 09/H0604/107) in order to assess the influence of genetic variation on the level of immunity to routine immunisations.
Conditions
- Immunization; Infection
Interventions
- OTHER
-
Collection of vaccine histories
Sponsors & Collaborators
-
University of Oxford
lead OTHER
Principal Investigators
-
Andrew Pollard Pollard, PhD · University of Oxford
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2014-10-31
- Completion
- 2016-10-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Pertussis Immunization Programs in Low Income Countries - Ivory Coast
NCT03388034 ·Status: COMPLETED
-
Immunity After COVID-19 Vaccination
NCT04883164 ·Status: UNKNOWN
-
Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
NCT00456183 ·Status: COMPLETED ·Phase: PHASE1
-
Heterologous Effects of BCG in Healthy UK Adults
NCT02380508 ·Status: COMPLETED ·Phase: NA
-
A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers
NCT00480688 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Safety and Immunogenicity of a Candidate MAP Vaccines ChAdOx2 HAV and MVA in Healthy Adult Volunteers
NCT03027193 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers
NCT00480714 ·Status: COMPLETED ·Phase: NA
-
Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors
NCT01602094 ·Status: UNKNOWN
-
Immunology of Non-specific Effects of Vaccine
NCT00168545 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults
NCT01879163 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine
NCT00654316 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG Vaccination
NCT00653627 ·Status: COMPLETED ·Phase: PHASE1
-
Pertussis Immunization Programs in Low Income Countries
NCT02983487 ·Status: COMPLETED
-
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
NCT00395720 ·Status: COMPLETED ·Phase: PHASE1
-
Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial
NCT05803538 ·Status: UNKNOWN ·Phase: NA
-
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
NCT00427830 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously
NCT00427453 ·Status: COMPLETED ·Phase: PHASE1
-
BCG Revaccination Study in Diabetic and Non-Diabetic Adults
NCT06246851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases
NCT05387655 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG
NCT00465465 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342
NCT01669096 ·Status: COMPLETED ·Phase: PHASE2
-
Risk of COVID-19 Infection After Vaccination
NCT04848441 ·Status: UNKNOWN
-
Testing the Use of Prompts to Increase Adolescent Immunization Rates
NCT01984125 ·Status: COMPLETED ·Phase: NA
-
Healthy, Immunized Communities Study
NCT03854734 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.
NCT00423566 ·Status: COMPLETED ·Phase: PHASE1